Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share (Pending:ZYBT)

China-based veterinary vaccine manufacturer—Zhengye Biotechnology (ZYBT) priced its initial public offering of 1.5M shares at a public offering price of $4.00 per share.

The shares have been approved for listing on the Nasdaq and are expected to commence trading on January 7, 2025, under